An oxymethylene aryl compound for treating inflammatory gastrointestinal diseases or gastrointestinal conditions

摘要

There is provided the use of an oxymethylene aryl GPR119 agonist, and optionally a DPP IV inhibitor and optionally metformin, for the treatment of inflammatory gastrointestinal disease or gastrointestinal conditions involving absorption of nutrients and / or fluids.